AdvanSix Inc.
Financials
Valuation Metrics
AdvanSix Inc.'s Market Cap is $419M. At end of 2025 it was $466M. Ranked #2819 of 3,116 in US market (top 90%), #1573 of 1,644 on NYSE (top 96%), #163 of 173 in Materials (top 94%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $419M | US#2,819/3,116 Sec#163/173 |
| Revenue | $1.56B | US#1,584/3,116 Sec#110/173 |
| Net Income | $-18M | US—/3,116 Sec—/173 |
| Total Assets | $1.67B | US#2,188/3,116 Sec#125/173 |
| Net Assets | $797M | US#1,913/3,116 Sec#118/173 |
| Employees | 1,410 | US#1,847/3,116 Sec#113/173 |
| Value | ||
| P/B | 0.53x | US#97/3,116 Sec#8/173 |
| P/S | 0.27x | US#132/3,116 Sec#8/173 |
| EV/EBITDA | 15.95x | US#1,578/3,116 Sec#112/173 |
| FCF Yield | -6.14% | US—/3,116 Sec—/173 |
| Profitability | ||
| ROE | -2.22% | US#2,184/3,116 Sec#124/173 |
| ROA | -1.06% | US#2,305/3,116 Sec#127/173 |
| Op. Margin | -1.42% | US#2,369/3,116 Sec#135/173 |
| Revenue Growth | 2.96% | US#1,955/3,116 Sec#111/173 |
| Earnings Growth | -122.92% | US#1,878/3,116 Sec#103/173 |
| Financial Health | ||
| Debt Ratio | 109.94% | US#1,179/3,116 Sec#102/173 |
| Total Debt | $424M | US#1,944/3,116 Sec#113/173 |
| FCF | $-26M | US#2,447/3,116 Sec#130/173 |
| Cash | $7M | US#2,996/3,116 Sec#168/173 |
| Current Ratio | 1.28x | US#1,896/3,116 Sec#151/173 |
| Net Debt/EBITDA | 7.95x | US#2,294/3,116 Sec#138/173 |
| Dividend | ||
| Div. Yield | 4.11% | US#376/3,116 Sec#21/173 |
| Div. Growth | 0.24% | US#1,217/3,116 Sec#76/173 |
| Performance | ||
| 1Y Return | -16.33% | US#2,465/3,116 Sec#144/173 |
| 1M Return | -4.10% | US#2,359/3,116 Sec#94/173 |
| From 52W High | -41.81% | US#2,498/3,116 Sec#126/173 |
| 1Y MDD | -42.57% | US#2,054/3,116 Sec#108/173 |
| Trading | ||
| Volume | 259,134 shares | US#2,561/3,116 Sec#141/173 |
| Trading Value | $4M | US#2,747/3,116 Sec#156/173 |
| Per Share | ||
| EPS | $-0.66 | US—/3,116 Sec—/173 |
| BPS | $29.56 | US#893/3,116 Sec#55/173 |
Company Info
AdvanSix Inc. operates as a global manufacturer and supplier of polymer resins, serving markets across the United States and internationally. A key offering is Nylon 6, a versatile synthetic polymer resin utilized in the production of fibers, filaments, specialized plastics, and films. The company's portfolio also includes caprolactam, an essential building block for other polymer resins, and ammonium sulfate fertilizers, which it distributes to farm cooperatives, retailers, and other channel partners. Furthermore, AdvanSix supplies acetone, a crucial ingredient for manufacturing adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins. Its extensive range additionally comprises various intermediate chemicals, such as phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide. These offerings are marketed under established brands like Aegis, Capra, Sulf-N, Nadone, Naxol, and EZ-Blox. AdvanSix utilizes a dual sales approach, engaging directly with customers while also leveraging a network of distributors. The company, established in 2016, is headquartered in Parsippany, New Jersey.